Profil News

Our expert

Dr. Lars Bochmann

Director Marketing & Business Development

February 18, 2020

Profil World - The clinical diabetes research newsletter - February 2020

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Upcoming

February 4, 2020

Type 1 Diabetes and mild cognitive impairment

Mild cognitive impairment: another complication of Diabetes mellitus type 1? Diabetes Mellitus (DM) is often considered a risk factor for mild cognitive impairment (MCI) and the association between

January 21, 2020

Free webinar on early phase obesity research

Profil continues the successful series of scientific webinars. On February 19th, 2020 we will air our free webinar on early phase obesity research. The session is presented by Dr. Daniela Lamers,

January 7, 2020

Trustworthy AI in healthcare - it's TIME TO DELIVER

In Europe chronic diseases account for 86% of deaths and 77% of disease burden, thereby creating a tremendous challenge on societies. At the same time digitisation is bringing huge technological and

December 23, 2019

Profil wishes merry christmas and a happy new year 2020

Another year has passed and the Profil blog has seen many interesting articles through the last months. We have posted about events, conferences, webinars, and interesting scientific topics for

December 10, 2019

Beer or wine or both – and if both, in which order?

Recent study investigates the impact of the combination and order of beer and wine on hangover severity “Beer before wine and you’ll feel fine, wine before beer and you’ll feel queer” or in German

November 26, 2019

Profil World - The clinical diabetes research newsletter - November 2019

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

November 14, 2019

Lipohypertrophy – New insights into an old issue?

Lipohypertrophy (LH) is a common side effect of insulin therapy in patients with diabetes mellitus. The prevalence of lipohypertrophy is high with cross-sectional studies reporting up to 64% of

October 17, 2019

What news in the treatment of Type 2 diabetes was presented at EASD 2019?

The annual meeting of the European Association for the Study of Diabetes (EASD) took place this year in Barcelona, Spain. The present text offers a selection of topics relevant for the field of type